StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Illumina hit with record $476 million fine

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Jul 27, 2023 6:52pm

122 Views

Post# 35560653

RE:Illumina hit with record $476 million fine

Yeah, at the rate szls is growing we should be able to take ova does Illumina sukas real soon now. Mark my words they are toast.
We have two weeks to get ourselves ready for the big bang when q2 results are sprung us poor suckers.
Today, not a single share changed hands on the exchange we are listed on. Never thought I would find an outfit as grossly unfit for purpose, other than the Liberal party of Canada.

Nailbiter2 wrote:

Illumina hit with record $476 million fine for closing Grail deal without EU approval

PUBLISHED WED, JUL 12 2023

https://www.cnbc.com/2023/07/12/illumina-hit-with-record-eu-fine-over-grail-deal.html